Apellis Pharmaceuticals Announces FDA Approval Of EMPAVELI Injector

Apellis Pharmaceuticals, Inc. (APLS) announced the FDA has approved the EMPAVELI Injector. It is a single-use, on-body device designed to enhance self-administration of EMPAVELI, which is approved for adults with paroxysmal nocturnal hemoglobinuria.

Related Keywords

,Bloomberg ,Invitae Common Hereditary Cancers Panel ,Apple Inc ,Motion Inc ,Google ,Microsoft Corp ,Us Consumer Product Safety Commission ,Microsoft ,Drug Administration ,Common Hereditary Cancers Panel ,California Based Future Motion ,Self Balancing Electric Skateboards ,Product Safety Commission ,Fda ,Apellis Pharmaceuticals ,Empaveli ,